Latest news on providing financial services expertise to ambitious growth companies, whether public or private. finnCap’s principal activities have until recently been equity capital markets focused and consisted of advising companies.

News

Better boards for growth companies

Better boards for growth companies

We are pleased to share our latest report – Better boards for growth companies, written in conjunction with the Quoted Companies Alliance. The report is based on a study, which surveyed over a hundred Non-Executive Directors (NEDs) of smaller quoted companies.

Why biogas is generating attention | finnCap Energy Insights

Why biogas is generating attention | finnCap Energy Insights

Why biogas is generating attention - Biogas and biomethane currently account for less than 3% of total bioenergy demand, but are gaining traction due to a number of benefits they offer the energy transition. Our latest Energy Insights report delves deeper.

In the business of carbon removal | finnCap Energy Insights

In the business of carbon removal | finnCap Energy Insights

Carbon removal becoming essential - As we are all too aware, the earth’s surface temperature is already over 1.0°C above pre-industrial levels and it is becoming increasingly clear that removing CO2 from the atmosphere will be necessary to reach global climate goals. Carbon Capture & Storage (CCS) and Direct Air Capture (DAC) are CO2 removal technologies that are key enablers for reaching global net zero emissions by 2050.

Why the energy storage market is set to explode | Energy Insights - May 2022

Why the energy storage market is set to explode | Energy Insights - May 2022

EV battery supply chains are already under pressure, stationary energy storage requirements are increasing and alternatives to lithium-ion are needed globally. Nevertheless, new battery chemistries are being commercialised and in this report we look at a panoply of battery technologies being developed.

Why 2022 will be a record year for cell and gene therapy | Life Sciences Insights - March 2022

Why 2022 will be a record year for cell and gene therapy | Life Sciences Insights - March 2022

Download the latest Life Sciences Insights, which heralds the encouraging new era of innovative technologies within the life sciences sector with long-term benefits and curative potential, Cell and Gene Therapy (CGT) which has been seen as the ‘future’ of medicine for many years. We are now closer than ever to that future becoming the present.

Direct to Consumer: Rite of Passage | Consumer Insights - Jan 2022

Direct to Consumer: Rite of Passage | Consumer Insights - Jan 2022

Direct-to-consumer is the biggest trend in retail today, but it is proving difficult for investors to make money from this secular shift at present. In this report, we highlight the cases, growth trajectories and strategies of leading DTC brands.

Digital change is impacting construction | Support Services Insights January 2022

Digital change is impacting construction | Support Services Insights January 2022

Digital change is sweeping across the construction industry, which is viewed as slow to change. As our latest Support Services Insights research shows, there are pockets of change and expertise in the supply chain, especially if we consider the Equipment Hire space.

A real stitch-up: Hiding behind ESG | Sustainability Insights January 2022

A real stitch-up: Hiding behind ESG | Sustainability Insights January 2022

Fast fashion is one of the least sustainable industries on the planet. Greenwashing is the latest in a slew of questionable behaviours within the fashion world and allegations will likely increase, bringing heightened investment risk. Our latest Sustainability Insights reports asks how can investors avoid this expensive trap?

Capital Performance - Winter 2022

Capital Performance - Winter 2022

finnCap Group is delighted to share the next edition of Capital Performance. This is our review of the second half of a remarkable 2021, and our look ahead to the next 12 months.

IPO Guide

IPO Guide

The finnCap IPO Guide provides an introduction to London's public stock markets, why you should consider an IPO, and what happens next.

Global Healthtech | IT in healthcare post COVID

Global Healthtech | IT in healthcare post COVID

The healthcare industry has been slow to adopt digital technology but it can bring efficiency, time savings and cost reductions - so what is the scenario for investors? Our Technology Sector Research team takes this opportunity to review the prospects of healthtech companies in light of the pandemic.